Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).
Journal: European journal of drug metabolism and pharmacokinetics
Published: April 28, 2024
Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I).
Journal: European journal of drug metabolism and pharmacokinetics
Published: April 28, 2024
A hybrid piezoelectric and triboelectric nanogenerator with lead-free BZT-BCT/PDMS composite and PVA film for scavenging mechanical energy.
Journal: RSC advances
Published: January 05, 2023
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.
Journal: Neuropsychiatric disease and treatment
Published: December 20, 2022
The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 29, 2022
Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections.
Journal: Neuropsychiatric disease and treatment
Published: May 18, 2022
Genome-wide association study meta-analysis of suicide death and suicidal behavior.
Journal: Molecular psychiatry
Published: February 22, 2022
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
Journal: The international journal of neuropsychopharmacology
Published: July 01, 2021
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
Journal: Patient preference and adherence
Published: June 01, 2021
Last Updated: 09/26/2026